Target intelligence / Profile preview

Centromere protein X (CENPX)

Target
CENPX
Molecular classification
Chromatin-associated protein, DNA-binding protein, Component of the Fanconi anemia complex, Constituent of kinetochore subcomplexes (CENP-S/CENP-X and MHF1/MHF2)
01

Overview

Centromere protein X (CENPX) is a highly conserved DNA-binding protein that plays dual roles in chromosome biology: (1) it is essential for proper kinetochore architecture and function, supporting accurate chromosome alignment and segregation during mitosis; (2) it acts as a DNA repair factor within the Fanconi anemia (FA) pathway, partnering with CENP-S (MHF1) and FANCM to facilitate the resolution of complex DNA structures and support the repair of interstrand crosslinks and stalled replication forks. Its functions are critical for maintaining genome stability, and mutations in CENPX are associated with disorders such as Fanconi anemia and certain types of osteogenesis imperfecta

Other names
CENPXFAAP10MHF2STRA13CENP-XMGC14480Stimulated by retinoic acid gene 13 protein homologFanconi anemia-associated histone fold protein 2Retinoic acid-inducible gene D9 protein homologFanconi anemia-associated polypeptide of 10 kDa
02

Mechanism of action

Mechanisms primarily relate to modulation of the Fanconi anemia DNA repair pathway, particularly the monoubiquitination of the FANCI-FANCD2 complex in response to DNA damage. Drugs that induce DNA cross-links may interact functionally by challenging the repair capacities mediated by CENPX/FANCM/MHF complex.

03

Biological functions

Double-stranded DNA bindingDNA repair (especially interstrand cross-link repair)Replication fork processingResolution of meiotic recombination intermediatesKinetochore assembly and maintenanceChromosome segregation
04

Disease associations

Fanconi anemia (complementation group T)Osteogenesis imperfecta (Type XII)Cancer (by implication through genome instability and DNA repair defects)
05

Safety considerations

No specific therapeutic safety concerns are attributed to direct targetingLoss-of-function or mutation risks include chromosomal breakageIncreased susceptibility to DNA damageGenomic instabilityTherapeutic challenges involve off-target effects and possible impact on cell viability due to its essential roles in cell division and genome integrity
06

Interacting drugs

DNA cross-linking agents (e.g., mitomycin C, cisplatin)
07

Biomarkers

CENPX (or CENPX gene expression and protein levels) is a potential biomarker for Fanconi anemia subtyping, and possibly for genetic contexts with impaired genome stability or DNA repair deficiency

Beyond the preview

Go deeper on Centromere protein X (CENPX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centromere protein X (CENPX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call